Jeffrey Stein - Mar 27, 2023 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Mar 27, 2023
Transactions value $
$51,855
Form type
4
Date filed
3/27/2023, 07:03 PM
Previous filing
Feb 23, 2023
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Purchase $51.9K +50K +21.59% $1.04 282K Mar 27, 2023 By trust F1
holding CDTX Common Stock 923K Mar 27, 2023 Direct
holding CDTX Common Stock 42K Mar 27, 2023 By son
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.015 to $1.0599. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.